Gerold Untergasser

Neuroendocrine differentiation of human prostatic primary epithelial cells in vitro.

Characterization of epithelial senescence by serial analysis of gene expression: identification of genes potentially involved in prostate cancer.

Trans-differentiation of prostatic stromal cells leads to decreased glycoprotein hormone alpha production.

Profiling molecular targets of TGF-beta1 in prostate fibroblast-to-myofibroblast transdifferentiation.

Benign prostatic hyperplasia: age-related tissue-remodeling.

Interferon-gamma induces neuroendocrine-like differentiation of human prostate basal-epithelial cells.

CD34+/CD133- circulating endothelial precursor cells (CEP): characterization, senescence and in vivo application.

The Dickkopf-homolog 3 is expressed in tumor endothelial cells and supports capillary formation.

Alternative splicing of vasohibin-1 generates an inhibitor of endothelial cell proliferation, migration, and capillary tube formation.

Dickkopf-3 as a new potential marker for neoangiogenesis in colorectal cancer: expression in cancer tissue and adjacent non-cancerous tissue.

Dysregulation of Dkk-3 expression in benign and malignant prostatic tissue.

Aging of the prostate epithelial stem/progenitor cell.

Quantification of circulating endothelial and progenitor cells: comparison of quantitative PCR and four-channel flow cytometry.

Dkk-3 expression in the tumor endothelium: a novel prognostic marker of pancreatic adenocarcinomas.

Adenoviral-mediated endothelial precursor cell delivery of soluble CD115 suppresses human prostate cancer xenograft growth in mice.

Vasohibin inhibits angiogenic sprouting in vitro and supports vascular maturation processes in vivo.

GRP-78 secreted by tumor cells blocks the antiangiogenic activity of bortezomib.

siRNA-mediated knock-down of P-glycoprotein expression reveals distinct cellular disposition of anticancer tyrosine kinases inhibitors.

Immunohistochemically detectable dickkopf-3 expression in tumor vessels predicts survival in gastric cancer.

Attenuated proliferation and trans-differentiation of prostatic stromal cells indicate suitability of phosphodiesterase type 5 inhibitors for prevention and treatment of benign prostatic hyperplasia.

Increased Dkk3 protein expression in platelets and megakaryocytes of patients with myeloproliferative neoplasms.

Distinct expression patterns of dickkopf genes during late embryonic development of Danio rerio.

Phosphodiesterase type 5 inhibition reverts prostate fibroblast-to-myofibroblast trans-differentiation.

Phenotype-dependent effects of EpCAM expression on growth and invasion of human breast cancer cell lines.

5-Methoxyleoligin, a lignan from Edelweiss, stimulates CYP26B1-dependent angiogenesis in vitro and induces arteriogenesis in infarcted rat hearts in vivo.

Favorable prognosis of operable non-small cell lung cancer (NSCLC) patients harboring an increased expression of tumor endothelial markers (TEMs).

EpCAM overexpression prolongs proliferative capacity of primary human breast epithelial cells and supports hyperplastic growth.

Marine compounds inhibit growth of multiple myeloma in vitro and in vivo.